10-Q: CNO Financial Group Reports Mixed Results in Q3 2024 Amidst Actuarial Review and Market Volatility

CNO Financial Group's Q3 2024 results show a complex picture with a net income of $9.3 million, impacted by an actuarial review and market fluctuations.

Summary

• CNO Financial Group reported a net income of $9.3 million for the third quarter of 2024, a significant decrease compared to $167.3 million in the same period last year.
• The company's insurance product margin increased to $282.2 million, up from $240.0 million in Q3 2023, driven by growth in the annuity, health and life segments.
• Net investment income rose to $299.5 million, a 7.0 percent increase year-over-year, due to portfolio growth and higher yields.
• A comprehensive annual actuarial review resulted in a net favorable impact of $27.3 million on pre-tax operating income, but also caused a $42.8 million unfavorable impact on pre-tax non-operating income due to changes in fair value of embedded derivative liabilities and market risk benefits.
• The company's estimated consolidated statutory RBC ratio was 388 percent at September 30, 2024, exceeding the target of 375 percent.
• CNO has raised its full-year operating earnings per diluted share guidance to a range of $3.50 to $3.60 and expects excess cash flow to the holding company to be between $250 million and $275 million.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with both positive and negative aspects. While the company shows growth in core business segments and a strong capital position, the significant decrease in net income and the impact of the actuarial review temper the overall sentiment. The raised guidance is a positive sign, but the risks and uncertainties remain.

Positives

• Insurance product margin increased year-over-year, indicating growth in core business segments.
• Net investment income saw a healthy increase due to portfolio growth and higher yields.
• The company's RBC ratio remains above the target level, indicating a strong capital position.
• Full-year operating earnings per diluted share guidance was raised, reflecting confidence in future performance.
• Excess cash flow to the holding company is expected to be higher than previously anticipated.

Negatives

• Net income decreased significantly compared to the same quarter last year.
• The actuarial review resulted in a significant unfavorable impact on pre-tax non-operating income.
• The company experienced net realized investment losses from sales, maturities and change in allowance for credit losses.
• The company experienced a decrease in earnings due to changes in the fair value of embedded derivative liabilities and market risk benefits.

Risks

• The company is exposed to market risks, including interest rate volatility and fluctuations in the financial markets.
• The ultimate outcome of lawsuits and regulatory proceedings could have a material adverse effect on the company.
• Changes in mortality, morbidity, and persistency rates could affect the profitability of insurance products.
• The company's ability to obtain adequate and timely rate increases on health products is a risk.
• The recoverability of deferred tax assets and the effect of potential ownership changes and tax rate changes on their value are risks.
• The company is subject to regulatory changes and actions that could impact its business.
• Cybersecurity attacks and data breaches pose a risk to the company's operations and sensitive data.

Future Outlook

CNO has raised its full-year operating earnings per diluted share guidance to a range of $3.50 to $3.60 and expects excess cash flow to the holding company to be between $250 million and $275 million. The company expects to continue to manage to a consolidated RBC ratio of 375 percent for its U.S. based insurance subsidiaries and minimum holding company liquidity of $150 million over the long term.

Industry Context

The report reflects the challenges and opportunities faced by insurance companies in a volatile market environment, including the impact of interest rate changes, market fluctuations, and regulatory changes. The company's focus on middle-income pre-retirees and retirees aligns with demographic trends, but also exposes it to specific risks related to this demographic.

Comparison to Industry Standards

• The company's RBC ratio of 388 percent is above the industry average, indicating a strong capital position.
• The company's investment portfolio is diversified across various asset classes, which is consistent with industry best practices.
• The company's focus on fixed indexed annuities is a common strategy in the insurance industry, but also exposes it to market risks.
• The company's expense ratio of 19.0 percent to 19.2 percent is within the range of industry benchmarks for similar companies.

Management Changes

Legal Proceedings

• The Company and its subsidiaries are involved in various legal actions in the normal course of business, in which claims for compensatory and punitive damages are asserted, some for substantial amounts.
• On June 7, 2019, Platinum Partners Value Arbitrage Fund L.P. (in Official Liquidation) ("PPVA"), the Joint Official Liquidators of PPVA (the "JOLs") and Principal Growth Strategies, LLC, ("PGS"), commenced suit against, among others, CNO Financial Group, Inc., Bankers Conseco Life Insurance Company ("BCLIC"), Washington National and 40|86 Advisors, Inc. (collectively, the "CNO Parties") in Delaware Chancery Court.
• On October 5, 2012, plaintiffs William Jeffrey Burnett and Joe H. Camp commenced an action entitled Burnett v. Conseco Life Ins. Co. against, among others, CNO Financial Group, Inc. and CNO Services, LLC (collectively, the "CNO Entities") in the United States District Court for the Central District of California on behalf of a putative class of former interest-sensitive whole life insurance policyholders who surrendered their policies or let them lapse.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net income, but may be encouraged by the raised guidance and strong capital position.
• Policyholders may be affected by changes in product features or pricing, but the company's strong financial position should provide reassurance.
• Employees may be affected by the workforce reduction, but the company is also planning to add roles in other areas.
• Creditors may be reassured by the company's strong capital position and ability to meet debt service obligations.

Next Steps

• The company expects to use a portion of the net proceeds from the issuance of the 2034 Notes for the repayment of its 2025 Notes.
• The company will continue to monitor market conditions and adjust its investment strategy as needed.
• The company will continue to evaluate the impact of regulatory changes and take appropriate actions.

Key Dates

Keywords

insurance, financial results, actuarial review, investment income, RBC ratio, net income, operating earnings, annuities, health insurance, life insurance, market risk, fixed indexed annuities